Acute intermittent porphyria is a genetic disorder of haem biosynthesis caused by defects in the gene encoding hydroxymethylbilane synthase on the long arm of chromosome 11. Every effort should be made to identify gene carriers amongst the relatives of patients known to have acute intermittent porphyria s they are at risk of developing potentially fatal neurogenic attacks if exposed to precipitating factors. Erythrocyte hydroxymethylbilane synthase activity was determined in 46 members of two large well characterised families by assaying enzyme activity by both high performance liquid chromatography (HPLC) and fluorimetric assays. Additionally, hydroxymethylbilane synthase immunoreactivity was determined by a sandwich-type ELISA. Statistically significant correlations were observed between erythrocyte hydroxymethylbilane synthase activity assayed by HPLC and by the fluorimetric assay, and enzyme protein concentration (r = 0.85, p < 0.001 and r = 0.80, p < 0.001, respectively). The assay of hydroxymethylbilane synthase immunoreactive concentration in erythrocytes was useful in excluding acute intermittent porphyria in one patient in whom unequivocal assignment of porphyric Status was not possible by assaying enzyme activity alone. Erythrocyte hydroxymethylbilane synthase activity assayed by HPLC and fluorimetry showed approximately equal diagnostic performances, both giving rise to a dichotomic distribution of values, with overlap zones of 6% (1/16) and 22% (2/9), respectively, at the "cut off' applied.
Introduction
should be made to identify gene carriers amongst the , . . i j · relatives of patients known to have acute intermittent Acute intermittent porphyria is an autosomal dominant . , " " t f : . . ,.,, j . porphyria (5) . Normal haem precursors usually occur m disorder of haem biosynthesis in which over-production >-Nevertheless, unequivocal s-" o . , 0 A^ signment confirming or refuting the diagnosis of acute camers \y·,. *·/· intermittent porphyria cannot be achieved among some It is important to investigate asymptomatic individuals re i a tives of a known patient with acute intermittent porfor latent or subclinical poφhyria and every eifort phyria due to the overiap in enzyme activities between affected patients and normal subjects (8) (9) (10) .
detected so far, make genetic studies in affected families an impractical Option at the present time. None of the mutations so far identified has been found to occur more frequently than any of the others, and many of these mutations appear to be unique to one family. Additionally, all polymorphic sites are clustered within a small fragment (1.5 X l O 3 bases in the first intron) of the hydroxymethylbilane synthase gene and thus limiting the usefulness of restriction fragment length polymorphisms in identifying and differentiating the mutant allele frorn the normal one (15) . However, restriction fragment length polymoφhisms have been successfully used for haplotype analysis and heterozygote canier detection in specific families with acute intermittent porphyria (16, 17) . In this study, the level of hydroxymethylbilane synthase gene expression in erythrocytes was determined in two large well characterised families by assaying hydroxymethylbilane synthase activity by both high performance liquid chroniatography (HPLC) of the reaction products (18) , and by a fluorimetric assay (19) . In addition, immunoreactive enzyme was assayed by ELISA (20) . The aim of this study was to assess the performance of assays measuring hydroxymethylbilane synthase activity, to document the degree of overlap in enzyme activities between gene camers and normal subjects using different methods, and secondly, to investigate whether determination of hydroxymethylbilane synthase immunoreactivity and specific enzyme activities have a better diagnostic performance in individuals with equivocal hydroxymethylbilane synthase activities.
Patients and Methods

Patient details
We studied 46 members from two large well characterised families: 33 members aged 2 to 70 years (mean ± SEM, 34.5 ± 3.4 years) (19 females and 14 males) were investigated from family l ( fig.  1 ), and 13 individuals aged 5 to 50 years (mean ± SEM, 28.2 ± 4.4 years) (7 females and 6 males) from family 2 (flg. 2) were studied. (19) with the assay of haemoglobin in the haemolysate (23). Enzyme activity was related to haemoglobin concentration and expressed s pkat/g Hb. The between-run coefficients of Variation of the fluorimetric assay were 2.1% and 5.4% for healthy and porphyric subjects, respectively. The lower reference limit applied was 90 pkat/g Hb, representing a diagnostic sensitivity of 97% and a specificity of 85%. Non-^gene carriers do not exhibit erythrocyte hydroxymethylbilane synthase activities below 70 pkat/g Hb, a value representing a "cut off' limit giving a sensitivity of 100%, but a low specificity of 47% (24).
Erythrocyte hydroxymethylbilane synthase concentration
Hydroxymethylbilane synthase concentration was assayed by a sandwich-type ELISA with monospecific polyclonal antiserum (IgG) raised against hydroxymethylbilane synthase, s previously described (20) . Haemoglobin concentration (absorbance read at 410 nm) of the samples was determined and hydroxymethylbilane synthase concentration was expressed relative to haemoglobin concentration s μg/g Hb. Erythrocytes hydroxymethylbilane synthase specific activity was determined by dividing enzyme activity with enzyme protein concentration, and expressed s nkat/g enzyme protein (20) . A lower reference limit of 110 μg/g Hb was used. This "cut off' Value gives a diagnostic sensitivity of 85% and specificity of 85% (24).
Further blood analyses
All patients had assays for f ll blood count, white cell differential and subset assays. Biochemical profile including renal and liver function and toxicity tests was carried-out on the DAX-48 multichannel analyser (Bayer Diagnostics, Basingstoke, UK) by Standard methods. 
Results
In the two families the propositus (patient III: 15, fig. 1 ; patient 111:2, fig. 2 ) presented at the age of 34 and 27 years, respectively, with a history of dieting prior to hospital admission. Both index patients were admitted to hospital with severe abdominal pain, hypertension, vomiting and constipation and had elevated urinary excretion of 5-aminolaevulinic acid, porphobilinogen, raised urinary porphyrin and normal faecal porphyrin (tab. 1). The decreased red cell hydroxymethylbilane synthase activity in both patients (assayed by HPLC, tab. 1) was consistent with the diagnosis of acute intermittent porphyria. All members investigäted from both families had normal biochemical profiles and haematological indices except 2 gene carriers from fämily 2 (patients 111:6 and IV:2, fig. 2 ) who had iron deficiency anaemia and a repeat hydroxymethylbilane synthase activity was performed after iron replacement therapy.
Discussion
The elevated urinary excretion of 5-aijiinolaevulinic acid and porphobilinogen in both index patients is consistent with the diägiiosis of one of the acute pörphyrias (i. e., acute intermittent porphyria, variegate porphyria and hereditary coproporphyria). The raised urinary porphyrin content (tab. 1) has probably arisen by non-enzymic polymerization of po hobilinogen in the urine to form a mixture of uropo hyrin isomers. The normal faecal porphyrin excretion in both patients indicates that variegate porphyria and hereditary coproporphyria are highly uftlikely, whereas the decreased red cell hydroxymethylbilane synthase activity (tab. 1) is consistent with acute intermittent porphyria.
The dominant mode of inheritance, the occurrence of asymptomatic gene carriers and the risk of developing potentially fatal attacks if exposed to a wide ränge of common precipitating factors, make it essential to exclude or confirm the diagnosis of acute intermittent porphyria in all relatives whenever the diagnosis has been made in one member of the fämily (2, 7). Patients with acute intermittent porphyria are at risk of developing potentially fatal neurogenic attacks if exposed to exogenous precipitating factors including a wide ränge of commonly prescribed drugs (25), alcohol, fasting, stress, hormones (2, 26) and, interestingly, if they continue to smoke (27). In our study, the index patients in both families had acute attacks of porphyria following low calorie diet for weight reduction.
In our haads the HPLC and fluorimetric assays for erythrocyte hydroxymethylbilane synthase activity showed about the same diagnostic efficiency at the "cut off" levels applied, 8 and 7 individuals, respectively, diagnosed äs gene carriers. However, it is clear that, whichever assay is used, there was a small overlap between enzyme activities in normal subjects and gene carriers in our study äs in previous studies (8) (9) (10) . It is well established that a definitive assignment of porphyric Status cannot always be made in all relatives, even when porphobilinogen excretion, 5-aminolaevulinic acid synthase activity (28) and gene dosage effect (9) are taken into account. Lamon et al. demonstrated that pedigree analysis with respect to Üie frequency distribution of hydroxymethylbilane synthase enzyme activities in family members was successful in establishing porphyric Status in 50% of those subjects with equivocal enzyme activity (9) . It is noteworthy that the existence of a variant of acute intermittent po hy ia has been reported where enzyme defect is not expressed in erythrocytes (29), in such families the measurement of erythrocyte hydroxymethylbilane synthase activity is unhelpful.
In this study, the measurement of erythrocyte hydroxymethylbilane synthase immunoreactive concentration was useful in excluding the diagnosis of acute intermittent pörphyria in one member who had equivocal hydroxymethylbilane synthase activity. The estimatiorl of enzyme specific activity was not useful in identifying gene carriers with no clear Separation between normal subjects and gene carriers. This is hardly surprising since there is a good correlation between hydroxymethylbilane synthase activity and enzyme protein concentration. This indicates that in these two families there is either no gene product or that the protein produced is neither catalytically active nor recognised by the anti-serum used in the ELISA, i. e., we are dealing with a form of acute intermittent pörphyria in whicfa no cross reacting immunoreactive material (CRIM) is iproduced (GRIM negative). Since hydroxymethylbilane synthase activity decreases äs red cells age any shift in their age distribution will be reflected in the enzyme activity (5), a repeat of hydroxymethylbilane synthase activity was essential in the two suspected gene carriers after the correction of the haematological abnormälities.
